Novo Nordisk
NVO
NVO
904 hedge funds and large institutions have $13.8B invested in Novo Nordisk in 2022 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 308 increasing their positions, 330 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 73 | Existing positions closed: 85
16% less capital invested
Capital invested by funds: $16.3B → $13.8B (-$2.53B)
28% less funds holding in top 10
Funds holding in top 10: 39 → 28 (-11)
Holders
904
Holding in Top 10
28
Calls
$183M
Puts
$125M
Top Buyers
| 1 | +$120M | |
| 2 | +$80.6M | |
| 3 | +$69.1M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$66.5M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$50M |
Top Sellers
| 1 | -$497M | |
| 2 | -$221M | |
| 3 | -$173M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$59.9M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$59.7M |